- 4-Week Delivery: World’s fastest custom mouse model development.
- TurboMice™ Tech: Proprietary high-efficiency gene-editing platform.
- Full Capabilities: Expert conditional knockouts, knock-ins, and humanized models.
- Validated Quality: Guaranteed high precision and model viability.
Treml1 KO Mouse Model
| Strain Name | Treml1 KO Mouse Model (M10048) |
|---|---|
| Editing Type | Knockout |
| Gene Name | Treml1 (triggering receptor expressed on myeloid cells-like 1; protein: TLT-1 / trem-like transcript 1; human ortholog *TREML1*) |
| Gene Synonyms | TLT-1; 5430401J17Rik |
| Strain Background | C57BL/6N |
| NCBI No. | Gene ID 71326 |

- Atherosclerosis & cardiovascular disease — Assess how loss of TLT-1 alters platelet-driven inflammation, leukocyte–endothelium interaction, and plaque progression; benchmark against the elevated circulating sTLT1 reported in apoE⁻/⁻ mice and coronary artery disease.
- Platelet activation & hemostasis — Use TLT-1 as a platelet activation endpoint (more sensitive than P-selectin) and interrogate α-granule release, aggregation, and the inflammation–hemostasis transition.
- Immune & inflammatory regulation — Dissect the contribution of membrane-bound versus soluble TLT-1 to innate immune responses; soluble TLT-1 acts as a DAMP through TLR4/MD2 in sepsis, and platelet-derived TLT-1 governs leukocyte transmigration in ALI/ARDS.
- Vascular injury & wound healing — Study TLT-1 in platelet aggregation at sites of vascular injury, hemorrhage protection, and wound repair.
- Osteoclast biology — Use the alternative TLT-1s transcripts, which inhibit TREM-2-mediated signaling during osteoclastogenesis, as a bone-remodeling entry point.
This mouse model carries a targeted knockout of the Treml1 gene, which encodes TLT-1 (TREM-like transcript 1), a member of the TREM receptor cluster. TLT-1 is stored in the α-granules of megakaryocytes and platelets and is rapidly surface-exposed upon platelet activation. It binds fibrinogen and modulates the transition between inflammation and hemostasis, dampening inflammatory responses while supporting platelet aggregation at sites of vascular injury; a soluble ectodomain fragment circulates in serum and can act as a damage-associated molecular pattern. This model removes TLT-1 function and provides an in vivo tool for resolving how platelet-derived signals shape vascular inflammation, hemostasis, and immune dysregulation.
- Platelet-centric, not myeloid-centric — TLT-1 localization to platelet α-granules is experimentally annotated (GO IDA); the model targets the platelet arm of TREM biology that myeloid-focused models miss.
- Sensitive activation readout — TLT-1 outperforms P-selectin as a platelet activation marker, giving a low-background endpoint for activation and granule-release assays.
- Inflammation–hemostasis crosstalk — TLT-1 uses fibrinogen to govern the switch between inflammation and hemostasis and facilitates controlled leukocyte transmigration, a readout poorly captured by conventional inflammation models.
- Separates membrane-bound from soluble TLT-1 — With circulating sTLT-1 acting as a TLR4/MD2 DAMP in sepsis, a knockout background cleanly isolates the contribution of the membrane-bound receptor.
- Vascular and translational reach — Elevated sTLT1 tracks with coronary artery disease and is raised in atherosclerotic apoE⁻/⁻ mice, supporting plaque, thrombosis, and ARDS/ALI studies on one strain.

FAQ
Game-changing benefits?
While competitors highlight germline efficiency gains, shorter timelines and enhanced 3Rs animal welfare benefits for their technologies, these are merely incremental improvements over traditional approaches. In sharp contrast, our proprietary technology delivers fully pure, homogeneous lineages—every single cell of the mice is derived exclusively from totipotent ES cells, with guaranteed 100% germline transmission efficiency. To experience these unparalleled benefits firsthand, enquire about your custom mouse model project with us or order embryos for in-house validation at your facility.
How much for a project assessment?
•Free initial design proposal with zero obligations.
•Request a free quote!
Who owns the mouse lP? Do l need a licence from Mingceler?
All model generation projects of Mingceler operate under a fee-for-service framework.
IP Ownership: All intellectual property rights related to custom mouse models, including derived organs, tissues, cells, and biological materials, are the sole and exclusive property of the Client.
Third-Party Transfer Permission: The Client may independently decide to retain, utilize, or commercialize their custom models project materials (e.g., targeting vectors, ES cells, mouse lines) without the need for prior consent from Mingceler.
Licensing Exemption: The Client has full autonomy over all uses of the custom models or their derivatives, including but not limited to commercialization, distribution to third parties, and publication involving model data. No written license from Mingceler is required for such uses.
